NCT06720207View on ClinicalTrials.gov

Efficacy of 68Ga-Pentixafor PET/MR in Detecting Non-Hodgkin Lymphoma and Multiple Myeloma Lesions

Not yet recruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2027

Conditions
Non Hodgkin's LymphomaMultiple Myeloma (MM)
All Listed Sponsors
lead

Shanghai East Hospital

OTHER

NCT06720207 - Efficacy of 68Ga-Pentixafor PET/MR in Detecting Non-Hodgkin Lymphoma and Multiple Myeloma Lesions | Biotech Hunter | Biotech Hunter